YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation
N -methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was shown to be associated with hepatocellular carcinoma (HCC) patient prognosis. However, the effect of YTHDF2 on liver CSC and cancer metastasis a...
Gespeichert in:
| Veröffentlicht in: | Oncogene Jg. 39; H. 23; S. 4507 - 4518 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Nature Publishing Group
04.06.2020
|
| Schlagworte: | |
| ISSN: | 0950-9232, 1476-5594, 1476-5594 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | N
-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was shown to be associated with hepatocellular carcinoma (HCC) patient prognosis. However, the effect of YTHDF2 on liver CSC and cancer metastasis and the molecular mechanism of this effect have not been documented. Here, we show that YTHDF2 expression is negatively correlated with HCC patient survival in both data from the Cancer Genome Atlas (TCGA) database and clinical data from our center. By detecting CD133
cells and carrying out sphere culture assays, we found that knockdown of YTHDF2 led to impaired stemness in Hep3B and Huh7 cells. In contrast, overexpression of YTHDF2 increased the CSC phenotype. Mechanistically, the knockdown and overexpression of YTHDF2 in liver cancer cells resulted in decreased and increased m6A levels in the 5'-untranslated region (UTR) of OCT4 mRNA, respectively, leading to decreased and increased OCT4 protein expression, respectively. A luciferase activity assay showed that mutation of the corresponding m6A methylation sequence in the 5'-UTR of OCT4 mRNA caused significantly decreased gene expression, suggesting a role for YTHDF2-dependent m6A methylation in protein translation. Polysome profiling results also indicated the knockdown and overexpression of YTHDF2 could decrease and increase OCT4 translation, respectively. In particular, overexpression of OCT4 rescued the impaired stemness caused by YTHDF2 depletion, which confirmed the effect of YTHDF2 on CSC phenotype is dependent on OCT4. In vivo, the loss of YTHDF2 reduced tumor burden and inhibited lung metastasis following orthotopic transplantation in nude mice. Last, we demonstrated that YTHDF2 expression is positively correlated with OCT4 expression and m6A levels in the 5'-UTR of OCT4 mRNA in clinical HCC specimens. In conclusion, YTHDF2 promotes the CSC liver phenotype and cancer metastasis by modulating the m6A methylation of OCT4 mRNA. |
|---|---|
| AbstractList | N
-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was shown to be associated with hepatocellular carcinoma (HCC) patient prognosis. However, the effect of YTHDF2 on liver CSC and cancer metastasis and the molecular mechanism of this effect have not been documented. Here, we show that YTHDF2 expression is negatively correlated with HCC patient survival in both data from the Cancer Genome Atlas (TCGA) database and clinical data from our center. By detecting CD133
cells and carrying out sphere culture assays, we found that knockdown of YTHDF2 led to impaired stemness in Hep3B and Huh7 cells. In contrast, overexpression of YTHDF2 increased the CSC phenotype. Mechanistically, the knockdown and overexpression of YTHDF2 in liver cancer cells resulted in decreased and increased m6A levels in the 5'-untranslated region (UTR) of OCT4 mRNA, respectively, leading to decreased and increased OCT4 protein expression, respectively. A luciferase activity assay showed that mutation of the corresponding m6A methylation sequence in the 5'-UTR of OCT4 mRNA caused significantly decreased gene expression, suggesting a role for YTHDF2-dependent m6A methylation in protein translation. Polysome profiling results also indicated the knockdown and overexpression of YTHDF2 could decrease and increase OCT4 translation, respectively. In particular, overexpression of OCT4 rescued the impaired stemness caused by YTHDF2 depletion, which confirmed the effect of YTHDF2 on CSC phenotype is dependent on OCT4. In vivo, the loss of YTHDF2 reduced tumor burden and inhibited lung metastasis following orthotopic transplantation in nude mice. Last, we demonstrated that YTHDF2 expression is positively correlated with OCT4 expression and m6A levels in the 5'-UTR of OCT4 mRNA in clinical HCC specimens. In conclusion, YTHDF2 promotes the CSC liver phenotype and cancer metastasis by modulating the m6A methylation of OCT4 mRNA. N6-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was shown to be associated with hepatocellular carcinoma (HCC) patient prognosis. However, the effect of YTHDF2 on liver CSC and cancer metastasis and the molecular mechanism of this effect have not been documented. Here, we show that YTHDF2 expression is negatively correlated with HCC patient survival in both data from the Cancer Genome Atlas (TCGA) database and clinical data from our center. By detecting CD133+ cells and carrying out sphere culture assays, we found that knockdown of YTHDF2 led to impaired stemness in Hep3B and Huh7 cells. In contrast, overexpression of YTHDF2 increased the CSC phenotype. Mechanistically, the knockdown and overexpression of YTHDF2 in liver cancer cells resulted in decreased and increased m6A levels in the 5′-untranslated region (UTR) of OCT4 mRNA, respectively, leading to decreased and increased OCT4 protein expression, respectively. A luciferase activity assay showed that mutation of the corresponding m6A methylation sequence in the 5′-UTR of OCT4 mRNA caused significantly decreased gene expression, suggesting a role for YTHDF2-dependent m6A methylation in protein translation. Polysome profiling results also indicated the knockdown and overexpression of YTHDF2 could decrease and increase OCT4 translation, respectively. In particular, overexpression of OCT4 rescued the impaired stemness caused by YTHDF2 depletion, which confirmed the effect of YTHDF2 on CSC phenotype is dependent on OCT4. In vivo, the loss of YTHDF2 reduced tumor burden and inhibited lung metastasis following orthotopic transplantation in nude mice. Last, we demonstrated that YTHDF2 expression is positively correlated with OCT4 expression and m6A levels in the 5′-UTR of OCT4 mRNA in clinical HCC specimens. In conclusion, YTHDF2 promotes the CSC liver phenotype and cancer metastasis by modulating the m6A methylation of OCT4 mRNA. N6-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was shown to be associated with hepatocellular carcinoma (HCC) patient prognosis. However, the effect of YTHDF2 on liver CSC and cancer metastasis and the molecular mechanism of this effect have not been documented. Here, we show that YTHDF2 expression is negatively correlated with HCC patient survival in both data from the Cancer Genome Atlas (TCGA) database and clinical data from our center. By detecting CD133+ cells and carrying out sphere culture assays, we found that knockdown of YTHDF2 led to impaired stemness in Hep3B and Huh7 cells. In contrast, overexpression of YTHDF2 increased the CSC phenotype. Mechanistically, the knockdown and overexpression of YTHDF2 in liver cancer cells resulted in decreased and increased m6A levels in the 5'-untranslated region (UTR) of OCT4 mRNA, respectively, leading to decreased and increased OCT4 protein expression, respectively. A luciferase activity assay showed that mutation of the corresponding m6A methylation sequence in the 5'-UTR of OCT4 mRNA caused significantly decreased gene expression, suggesting a role for YTHDF2-dependent m6A methylation in protein translation. Polysome profiling results also indicated the knockdown and overexpression of YTHDF2 could decrease and increase OCT4 translation, respectively. In particular, overexpression of OCT4 rescued the impaired stemness caused by YTHDF2 depletion, which confirmed the effect of YTHDF2 on CSC phenotype is dependent on OCT4. In vivo, the loss of YTHDF2 reduced tumor burden and inhibited lung metastasis following orthotopic transplantation in nude mice. Last, we demonstrated that YTHDF2 expression is positively correlated with OCT4 expression and m6A levels in the 5'-UTR of OCT4 mRNA in clinical HCC specimens. In conclusion, YTHDF2 promotes the CSC liver phenotype and cancer metastasis by modulating the m6A methylation of OCT4 mRNA.N6-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was shown to be associated with hepatocellular carcinoma (HCC) patient prognosis. However, the effect of YTHDF2 on liver CSC and cancer metastasis and the molecular mechanism of this effect have not been documented. Here, we show that YTHDF2 expression is negatively correlated with HCC patient survival in both data from the Cancer Genome Atlas (TCGA) database and clinical data from our center. By detecting CD133+ cells and carrying out sphere culture assays, we found that knockdown of YTHDF2 led to impaired stemness in Hep3B and Huh7 cells. In contrast, overexpression of YTHDF2 increased the CSC phenotype. Mechanistically, the knockdown and overexpression of YTHDF2 in liver cancer cells resulted in decreased and increased m6A levels in the 5'-untranslated region (UTR) of OCT4 mRNA, respectively, leading to decreased and increased OCT4 protein expression, respectively. A luciferase activity assay showed that mutation of the corresponding m6A methylation sequence in the 5'-UTR of OCT4 mRNA caused significantly decreased gene expression, suggesting a role for YTHDF2-dependent m6A methylation in protein translation. Polysome profiling results also indicated the knockdown and overexpression of YTHDF2 could decrease and increase OCT4 translation, respectively. In particular, overexpression of OCT4 rescued the impaired stemness caused by YTHDF2 depletion, which confirmed the effect of YTHDF2 on CSC phenotype is dependent on OCT4. In vivo, the loss of YTHDF2 reduced tumor burden and inhibited lung metastasis following orthotopic transplantation in nude mice. Last, we demonstrated that YTHDF2 expression is positively correlated with OCT4 expression and m6A levels in the 5'-UTR of OCT4 mRNA in clinical HCC specimens. In conclusion, YTHDF2 promotes the CSC liver phenotype and cancer metastasis by modulating the m6A methylation of OCT4 mRNA. |
| Author | Hou, Baohua Huang, Shanzhou Ji, Fei He, Xiaoshun Zhang, Chuanzhao Huang, Kaijun Ma, Zuyi Zhou, Zixuan Ruan, Shiye Zhuang, Hongkai |
| Author_xml | – sequence: 1 givenname: Chuanzhao orcidid: 0000-0001-6553-4458 surname: Zhang fullname: Zhang, Chuanzhao email: 641703837@qq.com organization: Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China. 641703837@qq.com – sequence: 2 givenname: Shanzhou surname: Huang fullname: Huang, Shanzhou organization: Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China – sequence: 3 givenname: Hongkai surname: Zhuang fullname: Zhuang, Hongkai organization: Shantou University of Medical College, Shantou, 515000, Guangdong Province, China – sequence: 4 givenname: Shiye surname: Ruan fullname: Ruan, Shiye organization: Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China – sequence: 5 givenname: Zixuan surname: Zhou fullname: Zhou, Zixuan organization: Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China – sequence: 6 givenname: Kaijun surname: Huang fullname: Huang, Kaijun organization: Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China – sequence: 7 givenname: Fei surname: Ji fullname: Ji, Fei organization: Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China – sequence: 8 givenname: Zuyi surname: Ma fullname: Ma, Zuyi organization: Shantou University of Medical College, Shantou, 515000, Guangdong Province, China – sequence: 9 givenname: Baohua surname: Hou fullname: Hou, Baohua email: 15917919681@163.com organization: Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China. 15917919681@163.com – sequence: 10 givenname: Xiaoshun surname: He fullname: He, Xiaoshun email: 13922171191@163.com organization: Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. 13922171191@163.com |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32366907$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kctK7EAQhhtRdLw8gBtpcOMmWn1JX5bDqEdBFGRcuAqdpOJEkk5MJ4OzO49-eji6cSEU_Iv66vJXHZJd33kk5JTBJQNhroJkwpgEOCRMgEj0DpkxqVWSplbukhnYFBLLBT8ghyG8A4C2wPfJgeBCKQt6Rv6-Lu-ubznth67tRgx0XCFt6jUOtHC-iBJGbGmBTUP7Ffpu3PRInS-_0y2OLsSoA803dMC3qXFj7d_o02IpKX72A4ZQd56ua0dbNafPj_Nt0Wqz5Tp_TPYq1wQ8-dIj8nJ7s1zcJQ9Pf-4X84ekkEqPidR5yRwDaZjQEkwOVZViXvKyqgC4qXIEqLRFBUXFeCmsTFlhWQpKOmVKcUQu_veNTj8mDGPW1mFry3nsppBxYY3iWjMT0fMf6Hs3DT5ul_F43Tie6_R3CizTcbSN1NkXNeUtllk_1K0bNtn3B8Q_fQeImA |
| CitedBy_id | crossref_primary_10_1038_s41575_021_00508_3 crossref_primary_10_1155_2022_7494354 crossref_primary_10_1007_s11427_023_2526_2 crossref_primary_10_3389_fonc_2022_763341 crossref_primary_10_1038_s41575_023_00884_y crossref_primary_10_3389_fgene_2022_934223 crossref_primary_10_1016_j_canlet_2025_217732 crossref_primary_10_1016_j_tox_2023_153673 crossref_primary_10_1371_journal_pone_0259669 crossref_primary_10_1158_0008_5472_CAN_22_2485 crossref_primary_10_3389_fcell_2021_736298 crossref_primary_10_3389_fonc_2023_1145766 crossref_primary_10_1111_jcmm_18517 crossref_primary_10_3389_fonc_2022_927810 crossref_primary_10_1007_s00535_023_02008_4 crossref_primary_10_1158_0008_5472_CAN_23_0337 crossref_primary_10_1186_s12943_022_01638_1 crossref_primary_10_1097_MD_0000000000030643 crossref_primary_10_1186_s40001_025_02812_z crossref_primary_10_1089_cbr_2023_0186 crossref_primary_10_3892_mmr_2025_13485 crossref_primary_10_1186_s40164_022_00269_y crossref_primary_10_3892_etm_2024_12543 crossref_primary_10_1007_s11427_023_2494_x crossref_primary_10_1016_j_bcp_2024_116419 crossref_primary_10_1111_1759_7714_13667 crossref_primary_10_1177_15330338241276895 crossref_primary_10_2147_CMAR_S272277 crossref_primary_10_3389_fonc_2022_654449 crossref_primary_10_1177_15353702231214266 crossref_primary_10_3389_fgene_2021_622233 crossref_primary_10_1080_21655979_2021_2001936 crossref_primary_10_3390_biomedicines10081918 crossref_primary_10_1080_21655979_2021_1933868 crossref_primary_10_1186_s12943_022_01652_3 crossref_primary_10_1038_s41598_022_13013_7 crossref_primary_10_3389_fimmu_2021_722642 crossref_primary_10_1007_s10555_023_10113_2 crossref_primary_10_1007_s00432_022_04162_3 crossref_primary_10_1186_s13046_022_02538_4 crossref_primary_10_1080_15384101_2025_2539643 crossref_primary_10_1186_s12943_024_02097_6 crossref_primary_10_1128_jvi_01655_21 crossref_primary_10_3390_cancers14225582 crossref_primary_10_1186_s40164_021_00227_0 crossref_primary_10_1155_2022_4416439 crossref_primary_10_1093_gpbjnl_qzae052 crossref_primary_10_3389_fphar_2022_984453 crossref_primary_10_3892_ol_2022_13370 crossref_primary_10_1016_j_tranon_2022_101602 crossref_primary_10_1038_s41598_025_92390_1 crossref_primary_10_1186_s12885_023_11794_2 crossref_primary_10_1155_2022_4169150 crossref_primary_10_3389_fendo_2022_972341 crossref_primary_10_3233_THC_230429 crossref_primary_10_3389_fimmu_2022_892750 crossref_primary_10_3389_fimmu_2023_1129298 crossref_primary_10_1007_s10565_025_10041_7 crossref_primary_10_1016_j_bmc_2023_117373 crossref_primary_10_3389_fonc_2021_755206 crossref_primary_10_1038_s41420_024_02261_3 crossref_primary_10_1007_s13258_022_01356_4 crossref_primary_10_1186_s12935_021_01807_0 crossref_primary_10_1002_bab_2777 crossref_primary_10_1016_j_canlet_2021_07_047 crossref_primary_10_1096_fj_202201061RR crossref_primary_10_1016_j_jhazmat_2024_136243 crossref_primary_10_3892_or_2024_8718 crossref_primary_10_1155_2022_8976179 crossref_primary_10_1084_jem_20210279 crossref_primary_10_1002_mog2_70015 crossref_primary_10_3389_fgene_2022_903117 crossref_primary_10_3389_fcell_2020_579919 crossref_primary_10_1002_ctm2_525 crossref_primary_10_1038_s41388_025_03408_x crossref_primary_10_1002_jcp_30907 crossref_primary_10_1007_s12672_024_00994_2 crossref_primary_10_1093_lifemedi_lnad008 crossref_primary_10_1002_advs_202302025 crossref_primary_10_3389_fonc_2020_623634 crossref_primary_10_1161_HYPERTENSIONAHA_124_22801 crossref_primary_10_3390_ijms25020981 crossref_primary_10_1097_MD_0000000000030045 crossref_primary_10_3389_fimmu_2025_1630311 crossref_primary_10_1016_j_yexcr_2025_114667 crossref_primary_10_3389_fphar_2024_1376005 crossref_primary_10_1186_s12943_022_01500_4 crossref_primary_10_1016_j_molcel_2025_05_015 crossref_primary_10_1016_j_freeradbiomed_2021_03_023 crossref_primary_10_1016_j_bcp_2024_116576 crossref_primary_10_1016_j_biopha_2023_114846 crossref_primary_10_1016_j_biochi_2025_05_001 crossref_primary_10_1186_s12964_023_01411_x crossref_primary_10_3389_fonc_2021_731957 crossref_primary_10_1016_j_ijbiomac_2025_143501 crossref_primary_10_1002_stem_3279 crossref_primary_10_1186_s40164_021_00234_1 crossref_primary_10_3389_fcell_2021_765635 crossref_primary_10_1093_nsr_nwad227 crossref_primary_10_1186_s13287_024_03846_6 crossref_primary_10_1007_s43657_021_00043_w crossref_primary_10_1038_s41401_023_01214_3 crossref_primary_10_1134_S1022795424700091 crossref_primary_10_3389_fcell_2021_767051 crossref_primary_10_1038_s41598_023_28527_x crossref_primary_10_3389_fonc_2021_681781 crossref_primary_10_1038_s41419_021_03625_8 crossref_primary_10_3389_fonc_2021_726018 crossref_primary_10_1186_s12964_023_01385_w crossref_primary_10_1016_j_ecoenv_2025_118839 crossref_primary_10_1186_s12935_023_03197_x crossref_primary_10_3389_fonc_2021_635329 crossref_primary_10_1089_scd_2021_0153 crossref_primary_10_1016_j_pan_2023_10_021 crossref_primary_10_1016_j_phrs_2021_105846 crossref_primary_10_1002_cti2_1393 crossref_primary_10_1186_s12943_025_02265_2 crossref_primary_10_3389_fgene_2021_752025 crossref_primary_10_3389_fphar_2022_873030 crossref_primary_10_1038_s41388_023_02707_5 crossref_primary_10_1111_cpr_13478 crossref_primary_10_1038_s41419_024_07317_x crossref_primary_10_3389_fonc_2025_1534948 crossref_primary_10_3389_fimmu_2023_1162607 crossref_primary_10_1016_j_canlet_2021_12_005 crossref_primary_10_1186_s13059_021_02308_z crossref_primary_10_3390_biology10080809 crossref_primary_10_1186_s13578_022_00788_5 crossref_primary_10_1155_2021_1328444 crossref_primary_10_1016_j_jnutbio_2022_109067 crossref_primary_10_1007_s00432_022_04158_z crossref_primary_10_1016_j_tips_2023_03_004 crossref_primary_10_3390_biom14080908 crossref_primary_10_1016_j_jia_2025_07_024 crossref_primary_10_1038_s41419_022_04817_6 crossref_primary_10_1002_advs_202307242 crossref_primary_10_3390_cancers12092601 crossref_primary_10_1186_s12951_021_01156_0 crossref_primary_10_1186_s12943_022_01619_4 crossref_primary_10_1002_prm2_12085 crossref_primary_10_3389_fcell_2021_687756 crossref_primary_10_3389_fonc_2025_1596541 crossref_primary_10_1093_femsre_fuad036 crossref_primary_10_1038_s41598_022_06744_0 crossref_primary_10_1186_s13062_024_00554_2 crossref_primary_10_1002_ctm2_602 crossref_primary_10_1002_ijc_34378 crossref_primary_10_1002_ctm2_848 crossref_primary_10_1016_j_clnves_2025_100008 crossref_primary_10_1186_s12863_023_01149_y crossref_primary_10_1007_s10565_024_09921_1 crossref_primary_10_1002_advs_202503851 crossref_primary_10_1007_s11010_022_04359_7 crossref_primary_10_3389_fmolb_2022_1096679 crossref_primary_10_1007_s10735_025_10551_y crossref_primary_10_1016_j_canlet_2024_216874 crossref_primary_10_3389_fcell_2024_1454587 crossref_primary_10_1186_s13578_024_01293_7 crossref_primary_10_1111_jcmm_18106 crossref_primary_10_3389_fonc_2022_858694 crossref_primary_10_1186_s12967_024_05701_x crossref_primary_10_1038_s41388_022_02214_z crossref_primary_10_1016_j_ymthe_2024_05_035 crossref_primary_10_3389_fmolb_2021_682471 crossref_primary_10_1111_febs_17299 crossref_primary_10_3892_ijmm_2024_5368 crossref_primary_10_1186_s12885_023_11524_8 crossref_primary_10_3389_fimmu_2022_917153 crossref_primary_10_1155_2021_2789481 crossref_primary_10_1016_j_semcancer_2022_03_018 crossref_primary_10_1111_jocd_70177 crossref_primary_10_3389_fimmu_2024_1439485 crossref_primary_10_1186_s12964_024_01595_w crossref_primary_10_1038_s41598_025_92428_4 crossref_primary_10_1016_j_canlet_2025_217439 crossref_primary_10_1038_s41598_020_80453_4 crossref_primary_10_1016_j_canlet_2021_03_009 crossref_primary_10_1007_s10620_024_08780_4 crossref_primary_10_1007_s00432_023_05045_x crossref_primary_10_1038_s41418_024_01423_1 crossref_primary_10_1177_11769351241300030 crossref_primary_10_1111_cpr_13164 crossref_primary_10_1038_s41392_023_01316_8 crossref_primary_10_1038_s41420_024_02256_0 crossref_primary_10_1007_s13258_022_01301_5 crossref_primary_10_3389_fimmu_2021_765723 crossref_primary_10_1038_s41420_024_01959_8 crossref_primary_10_1002_ctm2_1784 crossref_primary_10_1158_0008_5472_CAN_23_1916 crossref_primary_10_1007_s10555_023_10120_3 crossref_primary_10_1186_s13148_023_01574_x crossref_primary_10_1007_s11684_024_1064_8 crossref_primary_10_1007_s00432_022_04345_y crossref_primary_10_1158_0008_5472_CAN_20_4107 crossref_primary_10_1186_s13046_021_01952_4 crossref_primary_10_1007_s13577_024_01044_3 crossref_primary_10_2478_acph_2025_0009 crossref_primary_10_3389_fgene_2021_707305 crossref_primary_10_1016_j_biopha_2024_116365 crossref_primary_10_1016_j_isci_2023_106754 crossref_primary_10_1016_j_toxlet_2023_01_010 crossref_primary_10_1186_s12935_025_03923_7 crossref_primary_10_1155_2022_9365046 crossref_primary_10_3390_cancers14164035 crossref_primary_10_3389_fphar_2022_1052177 crossref_primary_10_1186_s12935_020_01696_9 crossref_primary_10_1038_s41419_022_04848_z crossref_primary_10_2147_CMAR_S551828 crossref_primary_10_3389_fimmu_2023_1100100 crossref_primary_10_3389_fcell_2021_777007 crossref_primary_10_3389_fimmu_2024_1417201 crossref_primary_10_1186_s12943_023_01877_w crossref_primary_10_3389_fcell_2022_935224 crossref_primary_10_3389_fphar_2021_707930 crossref_primary_10_1016_j_cej_2024_154173 crossref_primary_10_1186_s13045_021_01124_z crossref_primary_10_1007_s00018_022_04387_y crossref_primary_10_1016_j_cellsig_2024_111231 crossref_primary_10_3389_fcell_2021_778582 crossref_primary_10_1186_s12885_025_14044_9 crossref_primary_10_3390_metabo14060325 crossref_primary_10_1155_2022_2513813 crossref_primary_10_1155_2022_2754836 crossref_primary_10_1016_j_exphem_2025_104862 crossref_primary_10_1016_j_gene_2024_149055 crossref_primary_10_1038_s41419_024_06931_z crossref_primary_10_1016_j_ebiom_2021_103271 crossref_primary_10_1186_s12951_025_03538_0 crossref_primary_10_3390_ncrna10010011 crossref_primary_10_1038_s41568_021_00380_y crossref_primary_10_1016_j_bbcan_2025_189299 crossref_primary_10_3389_fendo_2022_1013238 crossref_primary_10_1007_s10238_025_01669_0 crossref_primary_10_1016_j_prp_2022_153794 crossref_primary_10_1042_EBC20220025 crossref_primary_10_1002_ddr_21942 crossref_primary_10_1002_cnr2_1970 crossref_primary_10_3389_fphar_2021_709548 crossref_primary_10_1007_s00441_021_03550_4 crossref_primary_10_3389_fcell_2021_651575 crossref_primary_10_3389_fcell_2021_681745 crossref_primary_10_3389_fmed_2023_1171023 crossref_primary_10_1186_s12935_022_02643_6 crossref_primary_10_1111_jgh_70015 crossref_primary_10_1016_j_bioorg_2025_108760 crossref_primary_10_1186_s43556_025_00314_2 crossref_primary_10_1002_mco2_70042 crossref_primary_10_3390_cancers17132220 crossref_primary_10_3390_cancers17132100 crossref_primary_10_1111_cas_15658 crossref_primary_10_1038_s41420_024_02084_2 crossref_primary_10_1016_j_aohep_2021_100538 crossref_primary_10_1007_s00018_022_04129_0 crossref_primary_10_3390_genes13112011 crossref_primary_10_1186_s12943_024_02132_6 crossref_primary_10_1038_s41419_024_06664_z crossref_primary_10_1016_j_biopha_2023_114669 crossref_primary_10_3389_fcell_2023_1264552 crossref_primary_10_3389_fmolb_2022_773662 crossref_primary_10_1007_s12038_022_00298_z crossref_primary_10_3389_fphar_2024_1383274 crossref_primary_10_1016_j_cellsig_2022_110440 crossref_primary_10_1186_s12935_022_02809_2 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Nature Limited 2020. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Limited 2020. |
| DBID | CGR CUY CVF ECM EIF NPM 3V. 7TM 7TO 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 |
| DOI | 10.1038/s41388-020-1303-7 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Research Library ProQuest Biological Science Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Research Library Prep Research Library Prep MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology |
| EISSN | 1476-5594 |
| EndPage | 4518 |
| ExternalDocumentID | 32366907 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -Q- .55 .GJ 0R~ 123 29N 2WC 36B 39C 3O- 4.4 406 53G 5RE 70F 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AACDK AANZL AASML AATNV AAYZH ABAKF ABAWZ ABBRH ABDBE ABDBF ABEFU ABFSG ABJNI ABLJU ABRTQ ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACPRK ACRQY ACSTC ACUHS ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AEZWR AFBBN AFDZB AFFNX AFHIU AFKRA AFSHS AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN AZQEC B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU CGR COF CS3 CUY CVF DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS ECM EE. EIF EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ITC IWAJR JSO JZLTJ KQ8 L7B LGEZI LK8 LOTEE M1P M2O M7P N9A NADUK NPM NQJWS NXXTH O9- OK1 OVD P2P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS UKHRP WH7 X7M ZXP ~8M 3V. 7TM 7TO 7U9 7XB 88A 8FD 8FK FR3 H94 K9. MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U RC3 7X8 PUEGO |
| ID | FETCH-LOGICAL-c467t-47bd1a1048137408b0ff5ebd2dff0028fbe00f79e60cf12d39451c915064a68d3 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 313 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000530271400004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0950-9232 1476-5594 |
| IngestDate | Fri Sep 05 10:14:48 EDT 2025 Mon Oct 06 18:33:18 EDT 2025 Mon Oct 06 17:49:39 EDT 2025 Mon Jul 21 06:07:16 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 23 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c467t-47bd1a1048137408b0ff5ebd2dff0028fbe00f79e60cf12d39451c915064a68d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-6553-4458 |
| PMID | 32366907 |
| PQID | 2409175069 |
| PQPubID | 36330 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2398627718 proquest_journals_2476740275 proquest_journals_2409175069 pubmed_primary_32366907 |
| PublicationCentury | 2000 |
| PublicationDate | 20200604 |
| PublicationDateYYYYMMDD | 2020-06-04 |
| PublicationDate_xml | – month: 6 year: 2020 text: 20200604 day: 4 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: New York |
| PublicationTitle | Oncogene |
| PublicationTitleAlternate | Oncogene |
| PublicationYear | 2020 |
| Publisher | Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group |
| SSID | ssj0007902 |
| Score | 2.693142 |
| Snippet | N
-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was... N6-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 4507 |
| SubjectTerms | 5' Untranslated regions Adenosine - analogs & derivatives Adenosine - metabolism Animals Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Cell culture DNA methylation Gene expression Gene Expression Regulation, Neoplastic - genetics Genomes Genotype & phenotype Hep G2 Cells Hepatocellular carcinoma Hepatocytes Humans Liver - pathology Liver cancer Liver Neoplasms - mortality Liver Neoplasms - pathology Lung cancer Male Medical prognosis Metastases Metastasis Methylation Mice Mice, Inbred BALB C Mice, Nude N6-methyladenosine Neoplasm Metastasis - pathology Neoplasm Transplantation Neoplastic Stem Cells - pathology Oct-4 protein Octamer Transcription Factor-3 - metabolism Phenotypes Prognosis RNA, Messenger - metabolism RNA-Binding Proteins - genetics Spheroids, Cellular Stem cells Translation Transplantation, Heterologous Tumor Cells, Cultured |
| Title | YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32366907 https://www.proquest.com/docview/2409175069 https://www.proquest.com/docview/2476740275 https://www.proquest.com/docview/2398627718 |
| Volume | 39 |
| WOSCitedRecordID | wos000530271400004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxEB7RFgoXHuEVKJGRuK66aztr7wmF0KgHso2qIIVTZK9tEYlu0mxakRs_nZl99FYuXCytvGutPeN5fpoB-OQTbezQuyj2Oo6kiiXeOSEj41F5actdZmpKf1N5rheLbNYG3KoWVtnJxFpQu3VBMfJTLqnsDCXZPm-uI-oaRdnVtoXGARxRlQRRQ_dmd5JYNZhDtCLiCA0Z3mU1hT6tUHgjj5DzRFI8UvdbmLWmmTz73398Dk9bG5ONGqZ4AQ982YNHTdfJfQ8ej7smbz04nra59Zfw58f8_OuEs00N0PMVQ9OQ_SLYBiuINbaMaj4zivQzAoatKXrLTOm66Su_M2hrVquK2T3bNk3uUTOyi_FcMv-7hdyW7HZl2FU6Ypf5iD76uW_weK_g--RsPj6P2v4MUYHidYeUtS4xCVWcEbhtbeMQht467kIgXy5YH8dBZT6Ni5BwJzI5TIqMahpKk2onXsNhuS79W2AoSbxNvUhCEaQOygx5YYUteJYYhS5hH066E1-2l6xaojGCziaudt90R40-fLybxvOlgzKlX9_gOyJDl06hgu7Dm4boy01T5mMpuEgpdvDu34u_hyec2IgiM_IEDnfbG_8BHha3u1W1HcCBWqh61DjqcTKAoy9n-ewSn6b8YlAzLI75bPoX3EPtxw |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6V8igXHoFCoMAiwdGqvbux1weEopQoVdNQoSCVk7u73i2RWifEaSE3fhG_kRk_eiu3HjivPbJmZ2e-mf08A_DORUqbnsuD0KkwkEko8cwJGWiHwUsZnqe62ulxMpmo4-P0aAP-tP_CEK2y9YmVo87nlmrku1xS2xm6ZPu4-BHQ1Ci6XW1HaNRmceDWPzFlKz_s7-H-vud8-Gk6GAXNVIHAolNY4feYPNIR9UkRKFCZ0PueMznPvacMxBsXhj5JXRxaH_FcpLIX2ZQ68Ukdq1yg3FtwG2EEVxVV8OjK8yc1xxFRSxggcOLtLapQuyUGC7RJStYoagTJ9Yi2imzDh_-bTh7BgwZDs35t9I9hwxUduFtP1Vx3YGvQDrHrwL3DhjvwBH5_m472hpwtKgKiKxlCX3ZGtBRmyfSXjHpaM7rJYER8m1N1mukib5fP3Uojli5nJTNrtnSn1eSz4pR9Hkwlc78aSnHBLmeancd99mXSp5e-r2u-4VP4eiNa2YbNYl6458DQUzoTOxF566Xyie5xa4SxPI10gilvF3baHc4aJ1JmCLYwmUZp1y23u9-Ft1fLqF9SlC7c_AKfESmmrAkCkC48q40sW9RtTDLBRUy1kRf_Fv4GtkbTw3E23p8cvIT7nEyYqlByBzZXywv3Cu7Yy9WsXL6uDgODk5u2tL-zGEOR |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VAi0XHqGUQIFFgqMVe3fjtQ8IRQlRq5ZQoSCVk9ld77aRqBPitJAbv4tfx4wfcCq3HjivPbJm5z2fZwBeuSjRpu_yIHRJGEgVStQ5IQPt0Hklhueprm76SE0myclJerwBv9p_YQhW2drEylDnc0s18h6XNHaGmmw938Aijkfjt4tvAW2Qok5ru06jFpFDt_6O6Vv55mCEd_2a8_G76XA_aDYMBBYNxAq_zeSRjmhmikDiiQm97zuT89x7yka8cWHoVeri0PqI5yKV_cimNJVP6jjJBdK9ATeVQCmmv9SHf-ElqsY7YgQTBhhE8bajKpJeiY4D5ZMSN_Iggbo6uq283Pje_8yf-3C3ia3ZoFaGB7Dhig7crrdtrjuwPWyX23Vg632DKXgIPz9P90djzhYVMNGVDENi9pXgKsySSiwZzbpm1OFgBIibU9Wa6SJvj8_dSmOMXc5KZtZs6U6rjWjFKfswnErmfjRQ44JdzjQ7jwfs42RAL52taxziDny6Fq48gs1iXrjHwNCCOhM7EXnrZeKV7nNrhLE8jbTCVLgLe-1tZ41xKTMMwjDJRmpXHbeS0IWXf46Rv8QoXbj5BT4jUkxlFQYmXditBS5b1ONNMsFFTDWTJ_8m_gK2UMCyo4PJ4VO4w0maqTgl92Bztbxwz-CWvVzNyuXzSi8YfLluQfsN3t9MBw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=YTHDF2+promotes+the+liver+cancer+stem+cell+phenotype+and+cancer+metastasis+by+regulating+OCT4+expression+via+m6A+RNA+methylation&rft.jtitle=Oncogene&rft.au=Zhang+Chuanzhao&rft.au=Huang+Shanzhou&rft.au=Zhuang+Hongkai&rft.au=Ruan+Shiye&rft.date=2020-06-04&rft.pub=Nature+Publishing+Group&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=39&rft.issue=23&rft.spage=4507&rft.epage=4518&rft_id=info:doi/10.1038%2Fs41388-020-1303-7&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon |